SPONSORED CONTENT On January 17th 2023, a letter was sent from the Tennessee Department of Health (DOH) to Tennesseans serving “as notification of changes in the HIV Program.” The letter informed federal grantees that they will no longer receive CDC…
SPONSORED CONTENT Recent surveys confirm what those of you reading this know painfully well: Hospital and clinic pharmacies are struggling from the restrictions drug manufacturers are placing on 340B pricing at contract pharmacy sites. As the 340B world awaits another […]
SPONSORED CONTENT The healthcare industry is grappling with a severe staffing shortage, and pharmacies are no exception. More than three-quarters of community pharmacists are struggling to fill open positions, and nearly 90% say finding pharmacy technicians is their top staffing […]
SPONSORED CONTENT Saving people’s lives.Eliminating the stigma surrounding a host of physical and mental health conditions.Advocating for the health equity of underserved populations.Executing targeted marketing campaigns. One of these initiatives indeed feels less service-oriented than the others. But once you […]
SPONSORED CONTENT The monkeypox (renamed mpox by the World Health Organization) outbreak took the world by storm in early May of 2022 on the heels of the COVID-19 pandemic. The AIDS Healthcare Foundation (AHF) was among the first public health […]
SPONSORED CONTENT Increasingly, participants in Accountable Care Organizations (ACOs) are discovering and benefiting from the 340B drug discount program. Unlike the historic fee-for-service healthcare models, ACOs are rewarded for outcomes that are better aligned with value-based population health, including improved […]
SPONSORED CONTENT We are pleased to again bring you Visante’s Top 10 issues in pharmacy for 2023. For 2022, our Top 10 items (Pharmacy Org Structure, 340B Program, Vertical Integration & Marketplace Restrictions, Drug Prices & Supply Chain, Infusion Services, […]
With increased scrutiny over passing on 340B discounts at the contract pharmacy counter, Hudson Headwaters 340B’s Jim Donnelly explores the matter and provides guidance on how to implement a successful program.
Which drugs, therapeutic classes, and medical specialties account for the largest savings realized through referral prescriptions within the contract pharmacy domain? Read this informative article by Cloudmed to find out.
Avita’s CEO Michael Yount and Chief Advocacy Officer Glen Pietrandoni discuss why 340B advocacy is so important and what Avita is doing to advocate for the 340B program community.
*Sign up for news summaries and alerts from 340B Report
